Journal article · 2025 · Open access
A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices
Aging Clinical and Experimental Research, 37(1), 172 · Published 27 May 2025 · DOI 10.1007/s40520-025-03073-w
In brief
“A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices” is a 2025 journal article by Moritz Platen and 9 co-authors, published in Aging Clinical and Experimental Research. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Aging Clinical and Experimental Research.
- Citations
- 0
- References
- 55
- Authors
- 10
Abstract
Background Various comorbidity indices have been validated for individual health outcomes. However, systematic concurrent comparisons of multiple outcome measures in a single study remain relatively underrepresented but needed for practical decision support. Aims To compare the performance of the Charlson Comorbidity Index (CCI) and Rx-Risk Comorbidity Index (Rx-Risk). Methods Baseline and six-month follow-up data from n = 221 patients recruited in n = 70 practices were used. CCI and Rx-Risk scores were calculated using documented diagnoses and prescribed medications. Outcomes assessed were health-related quality of life (HRQoL, EQ-5D-5 L), functional impairment (B-ADL), cognitive decline (MMSE), and healthcare utilization (physician visits, hospitalizations). Indices performance was evaluated regarding agreement (Cohens Kappa (k)), known-groups validity (ANOVA, t-test), convergent validity (correlation coefficient (r s )) and predictive ability (R², Akaike information criterion (AIC)). Results Patients were, on average, 80 years old, mostly female (55%), with 12 diagnoses and seven medications. Agreement between both indices was poor for all conditions except diabetes (k = 0.645) and chronic airway diseases (k = 0.486). Rx-Risk differed more in known groups, especially for HRQoL and hospitalizations, and showed stronger correlations with the EQ-5D index (r s , -0.215 vs. -0.134) and risk of hospitalization (r s , 0.145 vs. 0.128) than CCI. Rx-Risk, again, performed better in predicting the change of EQ-5D index (R², 30 vs. 28%) and all EQ-5D dimensions, functional (R², 55 vs. 52%) and cognitive decline (R², 47 vs. 46%) and physician consultations (AIC, 649.2 vs. 651.0), except for hospitalization (AIC, 149.2 vs. 147.1). Conclusions Rx-Risk demonstrated slightly superior validity and predictive ability for HRQoL and healthcare utilization, making it a promising option for studies focused on these outcomes. However, limitations regarding functional and cognitive impairment suggest alternative instruments are needed.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Platen, M., Buchholz, M., Rädke, A., Kleinke, F., Scharf, A., Pfaff, M., Iskandar, A., van den Berg, N., Hoffmann, W., & Michalowsky, B. (2025). A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices. Aging Clinical and Experimental Research, 37(1), 172. https://doi.org/10.1007/s40520-025-03073-w
MLA 9
Platen, Moritz, et al. “A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices.” Aging Clinical and Experimental Research, vol. 37, no. 1, 2025, p. 172. https://doi.org/10.1007/s40520-025-03073-w.
Chicago
Platen, Moritz, Maresa Buchholz, Anika Rädke, Fabian Kleinke, Annelie Scharf, Magdalena Pfaff, Arif Iskandar, Neeltje van den Berg, Wolfgang Hoffmann, and Bernhard Michalowsky. 2025. “A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices.” Aging Clinical and Experimental Research 37 (1): 172. https://doi.org/10.1007/s40520-025-03073-w.
Harvard
Platen, M. et al. (2025) ‘A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices’, Aging Clinical and Experimental Research, 37(1), p. 172. doi:10.1007/s40520-025-03073-w.
IEEE
M. Platen et al., “A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices,” Aging Clinical and Experimental Research, vol. 37, no. 1, p. 172, 2025, doi: 10.1007/s40520-025-03073-w.
BibTeX
@article{platen2025head,
title = {{A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices}},
author = {Platen, Moritz and Buchholz, Maresa and Rädke, Anika and Kleinke, Fabian and Scharf, Annelie and Pfaff, Magdalena and Iskandar, Arif and van den Berg, Neeltje and Hoffmann, Wolfgang and Michalowsky, Bernhard},
journal = {Aging Clinical and Experimental Research},
year = {2025},
volume = {37},
number = {1},
pages = {172},
doi = {10.1007/s40520-025-03073-w},
url = {https://doi.org/10.1007/s40520-025-03073-w}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- comorbidity index
- Charlson Comorbidity Index
- health-related quality of life
- EQ-5D
- functional disability
- activities of daily living
- cognitive decline
- health care utilization
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Platen, M., Buchholz, M., Rädke, A., Kleinke, F., Scharf, A., Pfaff, M., Iskandar, A., van den Berg, N., Hoffmann, W., & Michalowsky, B. (2025). A head-to-head comparison of the validity and predictive ability for health outcomes of diagnosis versus medication-based comorbidity indices. Aging Clinical and Experimental Research, 37(1), 172. https://doi.org/10.1007/s40520-025-03073-w
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Aging Clinical and Experimental Research.
Who wrote this paper?
Moritz Platen, Maresa Buchholz, Anika Rädke, Fabian Kleinke, Annelie Scharf, Magdalena Pfaff, Arif Iskandar, Neeltje van den Berg, Wolfgang Hoffmann, Bernhard Michalowsky.
What is the DOI of this paper?
10.1007/s40520-025-03073-w. The permanent link is https://doi.org/10.1007/s40520-025-03073-w.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.